67
Participants
Start Date
May 22, 2017
Primary Completion Date
December 11, 2020
Study Completion Date
May 18, 2021
Bleselumab
Intravenous infusion
Basiliximab
Bolus injection
Mycophenolate Mofetil (MMF)
Oral Intravenous
Tacrolimus Capsules
Oral Capsule
Methylprednisone
Oral or Intravenous
Prednisone
Oral Tablet
Columbia University Medical Center, New York
Erie County Medical Center, Buffalo
University of Pennsylvania Health System, PCAM, Philadelphia
University of Virginia, Charlottesville
Duke University Medical Center, Durham
University of North Carolina, Chapel Hill
Medical University of South Carolina, Charleston
University of Miami, Miami
University of Louisville, Louisville
Indiana University, Indianapolis
Michigan Medicine, Ann Arbor
University of Chicago, Chicago
Washington University in St. Louis, St Louis
Tulane University Health Service Center, New Orleans
University of Colorado, Aurora
University of Utah Medical Center, Salt Lake City
University of Arizona, Tucson
UCSF, San Francisco
Stanford School of Medicine, Palo Alto
St. Barnabas, Livingston
Site CA15002, Edmonton
Site CA15005, Vancouver
Site CA15006, Montreal
Kyowa Kirin Co., Ltd.
INDUSTRY
Astellas Pharma Global Development, Inc.
INDUSTRY